Article
Portable, and ultrasensitive HR-HPV tests based on nucleic acid biosensors
28 Feb 2024
Abstract excerpt
Cervical cancer is the third most common cancer threatening women's health globally, and high-risk human papillomavirus (HR-HPV) infection is the main cause of cervical cancer worldwide. Given the recurrent nature of HR-HPV infection, accurate screening is essential for its control. Since the commonly used polymerase chain reaction (PCR) technique is limited by professional equipment and personnel, convenient and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
